The Latest Regenerative Medicine Articles from Streetwise Reports


Organogenesis Shares Rise 20% on Q3 Net Revenue Growth and FY Guidance

  ()
Shares of Organogenesis Holdings traded higher after the company reported preliminary Q3/20 financial results demonstrating a 55% increase in year-over-year revenue. read more >

Phase 3 COVID-19 Study of Firm's Stem Cell Product Exceeds 50% Enrollment

Research Report
  ()
The study design and goals and Mesoblast's next steps are reviewed in a Dawson James Securities report. read more >

Regenerative Medicine Firm Reports Early Results from COVID-19 Trials

Research Report
  ()
Pluristem Therapeutics' coronavirus clinical studies and financing are discussed in a Dawson James report. read more >
Showing Results: 1 to 3 of 3

Get Our Streetwise Reports Resources Report Newsletter Free and be the first to know!

A valid email address is required to subscribe